电脑桌面
添加51搜公文到电脑桌面
安装后可以在桌面快捷访问

艾昆纬-克服商业领袖的7大挑战(英)-2024-11页.pdfVIP专享VIP免费优质

艾昆纬-克服商业领袖的7大挑战(英)-2024-11页.pdf_第1页
1/11
艾昆纬-克服商业领袖的7大挑战(英)-2024-11页.pdf_第2页
2/11
艾昆纬-克服商业领袖的7大挑战(英)-2024-11页.pdf_第3页
3/11
Overcoming 7 Top Challenges of Commercial LeadersPractical Strategies for Addressing Persistent IssuesAs the life sciences industry becomes increasingly competitive, digital, and complex, commercial leaders are turning to comprehensive, centralized omnichannel approaches grounded in data, advanced analytics, and deep domain expertise. A recent report assessing industry advertising budgets found that pharma ad spend continues to grow, marking a year-over-year increase of 12 percent—with most of those new dollars spent on digital activities.1 While, in theory, these investments can support improved personalization and commercial effectiveness, many marketers have yet to observe a significant measurable impact.A survey of 130 biopharma executives conducted by Industry Dive set out to pinpoint what’s causing this disconnect. Seven key factors emerged, including organizational silos, data exchange problems, and a lack of tech integration. In this playbook, with the help of biopharma experts, we’re exploring practical solutions pharma leaders can use to navigate and overcome them. The pages that follow summarize the survey findings and offer actionable recommendations on overcoming each key challenge grounded in expert perspectives.1. https://www.standardmediaindex.com/insights/u-s-smi-core-release-note-september-2022/Biqvia.comChallenge 1: Interdepartmental silos “It’s unsurprising that the top challenge leaders experience is organizational silos,” says Pooja Jain, Global Director of Orchestrated Analytics at IQVIA. “Not only is this causing major operational inefficiency, but it has a significant impact on brand performance due to outreach programs lacking true omnichannel personalized engagement for each and every HCP.” For instance, MSLs and reps might independently develop their own engagement strategies such that it creates a duplication of efforts and more touchpoints than HCPs care to have, she said. This can lead to HCP disengagement, which, in turn, will affect prescribing behavior. Therefore, leaders across departments not only benefit from shared visibility of everyone’s upcoming engagement plans but also meaningful, data-informed coordination of those activities from pre- to post-launch.“A ‘360 viewpoint’ can provide a deep, near real-time understanding of your targets, which can inform a team-coordinated engagement approach built around high-value HCP segments,” Jain said. “Moreover, embedding AI/ML for more accurate, transparent, and predictive engagement insights can further support coordination. The key is to make sure everything is linked to business objectives and that the outcomes are measurable. This can help motivate teams to work together as they see the benefits of teamwork.”However, Jain also points out that breaking down these silos requires an institutional and cultural shift that focuses on holistic collaboration. In response, some commercial teams...

1、当您付费下载文档后,您只拥有了使用权限,并不意味着购买了版权,文档只能用于自身使用,不得用于其他商业用途(如 [转卖]进行直接盈利或[编辑后售卖]进行间接盈利)。
2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。
3、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。

碎片内容

艾昆纬-克服商业领袖的7大挑战(英)-2024-11页.pdf

您可能关注的文档

无忧公文+ 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

确认删除?
QQ
  • QQ点击这里给我发消息
回到顶部